+149.2%
MRNA vs LBRT
-36.5%
+185.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | LBRT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -0.1% | -4.8% | -4.8% |
| 7D | -20.9% | -6.7% | -14.2% | -20.2% |
| 30D | -13.3% | -29.5% | +16.3% | -10.0% |
| 3M | +212.6% | -43.2% | +255.8% | +230.0% |
| 6M | +309.0% | -63.3% | +372.4% | +372.4% |
| YTD | +567.3% | -34.1% | +601.4% | +549.8% |
| 1Y | +689.7% | -25.5% | +715.2% | +643.0% |
| All | +149.2% | -36.5% | +185.7% | +137.4% |
Cumulative growth
Daily Returns
Daily percentage return beside LBRT.
Daily Out/Under-Performance
Portfolio return minus LBRT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LBRT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded LBRT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling